Helen Meadows

3.4k citations

36 papers · 2.3k indexed · 2 hit papers · h-index 19

Impact in

Surgery top 1%
- Colorectal and Anal Carcinomas
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Diagnosis and treatment of tuberculosis
- Surgical site infection prevention
Oncology top 2%
- Colorectal Cancer Surgical Treatments

Papers in

Parasitology 5
- Parasites and Host Interactions 5
Surgery 29
- Colorectal and Anal Carcinomas 27
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Bladder and Urothelial Cancer Treatments 4

Co-authors: David Sebag‐Montefiore Rob Glynne‐Jones R.D. James David Cunningham JA Ledermann John Northover Tim Maughan Latha Kadalayil
Journals: Journal of Clinical Oncology (10 papers)Annals of Oncology (4 papers)Molecular and Biochemical Parasitology (4 papers)British Journal of Cancer (3 papers)The Lancet Oncology (3 papers)
Partner nations: United Kingdom Czechia United States

In The Last Decade

Helen Meadows

36 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial 2013 · 459 citations

Peers

Countries citing papers authored by Helen Meadows

Since Specialization

Citations

This map shows the geographic impact of Helen Meadows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Meadows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Meadows more than expected).

Fields of papers citing papers by Helen Meadows

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Meadows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Meadows. The network helps show where Helen Meadows may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Helen Meadows, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Meadows Line = papers co-authored together Helen Meadows links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals Trials ·(unknown), Eleanor Mitchell, Kirsteen Goodman, Suzanne Hartley, Helen Hickey, Alison McDonald, Helen Meadows, Shelley Rhodes, Jodi Taylor, D Szlabowicz, Barbara Farrell	2020	3
2	Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC) European Journal of Cancer ·Eleonor Rivin del Campo, Oscar Matzinger, Karin Haustermans, D. Peiffert, Rob Glynne‐Jones, Kathryn Winter, André Konski, Jaffer A. Ajani, J.F. Bosset, Jean‐Michel Hannoun‐Lévi, Marc Puyraveau, A. Bapsi Chakravarthy, Helen Meadows, John Northover, Laurence Collette, Melissa Christiaens, P. Maingon	2019	7
3	Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial The Lancet Oncology ·Rob Glynne‐Jones, David Sebag‐Montefiore, Helen Meadows, David Cunningham, Rubina Begum, F. Adab, Kim Benstead, Robert Harte, Jill Stewart, Sandy Beare, Allan Hackshaw, Latha Kadalayil	2017	94
4	Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial Annals of Oncology ·Rob Glynne‐Jones, Latha Kadalayil, Helen Meadows, David Cunningham, Leslie Samuel, J I Geh, C. Lowdell, R.D. James, Sandy Beare, Rubina Begum, JA Ledermann, David Sebag‐Montefiore	2014	36
5	Chronicle: a Phase III Trial in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Randomising Postoperative Adjuvant Capecitabine/Oxaliplatin Versus Control Annals of Oncology ·R. Glynne‐Jones, Nicholas Counsell, Helen Meadows, Jonathan A. Ledermann, David Sebag‐Montefiore	2013	3
6	Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial The Lancet Oncology ·R.D. James, Rob Glynne‐Jones, Helen Meadows, David Cunningham, Arthur Sun Myint, Mark Saunders, Tim Maughan, Alec McDonald, Sharadah Essapen, Martin Leslie, Stephen Falk, Charles B. Wilson, Simon Gollins, Rubina Begum, Jonathan A. Ledermann, Latha Kadalayil, David Sebag‐Montefiore Hit paper breakdown →	2013	459
7	Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma Photodiagnosis and Photodynamic Therapy ·Stephen P. Pereira, Guruprasad P. Aithal, Krish Ragunath, John Devlin, Jürgen Suda, Helen Meadows	2012	19
8	Prognostic factors for recurrence and survival in anal cancer Cancer ·Rob Glynne‐Jones, David Sebag‐Montefiore, Richard Adams, Simon Gollins, Mark Harrison, Helen Meadows, Mark Jitlal	2012	59
9	Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): Long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin Radiotherapy and Oncology ·David Sebag‐Montefiore, Helen Meadows, David Cunningham, P N Plowman, David Hurman, Neville Davidson, Robert Grieve, YU CHEN, Rob Glynne‐Jones	2012	23
10	“Mind the Gap”—The Impact of Variations in the Duration of the Treatment Gap and Overall Treatment Time in the First UK Anal Cancer Trial (ACT I) International Journal of Radiation OncologyBiologyPhysics ·Rob Glynne‐Jones, David Sebag‐Montefiore, Richard Adams, Alec McDonald, Simon Gollins, R.D. James, John Northover, Helen Meadows, Mark Jitlal	2010	40
11	A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II) Journal of Clinical Oncology ·Lai Shuyi, Susan Wan, R. Glynne‐Jones, David Sebag‐Montefiore, Latha Kadalayil, John Northover, David Cunningham, Helen Meadows, JA Ledermann	2009	31
12	A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II) Journal of Clinical Oncology ·Lai Shuyi, Shanshan Wan, R. Glynne‐Jones, David Sebag‐Montefiore, Latha Kadalayil, John Northover, David Cunningham, Helen Meadows, JA Ledermann	2009	58
13	EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer International Journal of Radiation OncologyBiologyPhysics ·Rob Glynne‐Jones, Helen Meadows, Susan Wan, Simon Gollins, Martin Leslie, YU CHEN, Alec McDonald, Sun Myint, Leslie Samuel, David Sebag‐Montefiore	2008	88
14	A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study British Journal of Cancer ·Rob Glynne‐Jones, S. Falk, Tim Maughan, Helen Meadows, David Sebag‐Montefiore	2007	43
15	A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study British Journal of Cancer ·David Sebag‐Montefiore, Rob Glynne‐Jones, S. Falk, Helen Meadows, Tim Maughan	2005	82
16	Pathological staging of epidermoid anal carcinoma for the new era Colorectal Disease ·James Hill, Helen Meadows, N. Haboubi, I C Talbot, John Northover	2003	17
17	Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin The Lancet ·S.J. Arnott, David Cunningham, James Gallagher, Richard Gray, J D Hardcastle, Jacob L. Houghton, R.D. James, Teresa Lennon, Helen Meadows, Jean Mossman, P Morawski, Jodok Zwahlen, P N Plowman, Mark Slevin Hit paper breakdown →	1996	581
18	Structure of the gene encoding a putative Schistosoma mansoni tegumental antigen precursor Molecular and Biochemical Parasitology ·Frederico G. C. Abath, Paul Hagan, S. A. Jeffs, Israël Schechter, Helen Meadows, Anthony A. Holder, Andrew J.G. Simpson	1993	7
19	Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni Molecular and Biochemical Parasitology ·任昌萍, S. A. Jeffs, Helen Meadows, Chenqixin, Carolyn A. Owen, Frederico G. C. Abath, ILHAM PADRI, Fiona Hackett, S. R. Smithers, Andrew J.G. Simpson	1991	20
20	Predicted structure of a major Schistosoma mansoni eggshell protein Molecular and Biochemical Parasitology ·Vanderlei Rodrigues, M. Chaudhri, Matty Knight, Helen Meadows, Anne Chambers, William R. Taylor, Charles Kelly, Andrew J.G. Simpson	1989	28

About Helen Meadows

Helen Meadows is a scholar working on Parasitology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 36 papers that have together received 2.3k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (27 papers), Colorectal Cancer Surgical Treatments (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Gastric Cancer Management and Outcomes (5 papers), Parasites and Host Interactions (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Surgery (2.1k citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (1.1k citations), Epidemiology (314 citations) and Parasitology (49 citations). Helen Meadows has collaborated with scholars based in United Kingdom, Czechia and United States. Frequent co-authors include David Sebag‐Montefiore, Rob Glynne‐Jones, R.D. James, David Cunningham, JA Ledermann, John Northover, Tim Maughan, Latha Kadalayil, Simon Gollins and Susan Wan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Molecular and Biochemical Parasitology, British Journal of Cancer and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact